EMA — authorised 19 March 2001
- Marketing authorisation holder: ABBVIE DEUTSCHLAND GMBH CO. KG
- Status: approved
🇪🇺 Kaletra in European Union
EMA authorised Kaletra on 19 March 2001
Marketing authorisation
Kaletra in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in European Union
Frequently asked questions
Is Kaletra approved in European Union?
Yes. EMA authorised it on 19 March 2001.
Who is the marketing authorisation holder for Kaletra in European Union?
ABBVIE DEUTSCHLAND GMBH CO. KG holds the EU marketing authorisation.